Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Donglin Yang

13PUBLICATIONS
27CO-AUTHORS
Haematological tumoursPlanning and decision makingTransplantation immunologyCardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

Sort by Publication Date:
|May 14, 2026
CBFB::MYH11 MRD after the second chemotherapy cycle: a guide for allogeneic transplantation in favorable-risk AML.

|Sep 25, 2025
Autonomous artificial intelligence prescribing a drug to prevent severe acute graft-versus-host disease in HLA-haploidentical transplants.

Junren Chen, Yigeng Cao, Yahui Feng

|May 21, 2025
Timing of achieving MRD negativity for B-ALL patients with IKZF1 alterations in CR1 may dictate transplant decision: Autologous versus Allogeneic HSCT.

Jiali Wang, Xiaoxiao Ma, Hongye Gao

|May 09, 2025
Divergent prognostic factors in high-risk vs. standard-risk patients aged 50-65 years after allo-HCT for AML/MDS: a single-center retrospective analysis.

Wenwen Guo, Haixiao Zhang, Hongye Gao

|Apr 25, 2025
Favorable outcomes and the association between dynamic transfusion dependence and IPSS-M in MDS-h and MDS-LB patients undergoing allo-HSCT.

Wenjing Guo, Jia Li, Hui Wang

|Mar 03, 2025
Increased Epstein-Barr virus reactivation but similar incidence of post-transplant lymphoproliferative disorders due to pre-emptive rituximab therapy following allogeneic hematopoietic stem cell transplantation in the letermovir era for cytomegalovirus prophylaxis.

Sisi Zhen, Li Liu, Xiaoyu Zhang

Pageof 3

Frequent Collaborators

10 joint publications

Erlie Jiang

9 joint publications

Yi He

6 joint publications

Mingzhe Han

5 joint publications

Mingyang Wang

5 joint publications

Sizhou Feng

2 joint publications

Haixiao Zhang

2 joint publications

Wenwen Guo

2 joint publications

Sizhou Feng

2 joint publications

Junren Chen

2 joint publications

Hui Wei

Frequent Collaborators

10 joint publications

Erlie Jiang

9 joint publications

Yi He

6 joint publications

Mingzhe Han

5 joint publications

Mingyang Wang